MetaboSeq: A clinical fatty acid oxidation disorders next-generation sequencing panel

C. Alexander Valencia
2013 Journal of Proteomics & Bioinformatics  
I nherited defects in mitochondrial fatty acid oxidation (FAO) are an important class of metabolic disorders, comprised of at least 12 distinct enzyme or transporter deficiencies. Mutations in the genes of this pathway have serious clinical consequences including hypoglycemic seizures, rhabdomyolysis, cardiomyopathy, metabolic acidosis, and hepatic encephalopathy. Newborn screening for FAOD promises to identify many affected patients before the onset of symptoms by screening for the
more » ... for the accumulation of specific biochemical markers such as acylcarnitine metabolites in blood and urinary dicarboxylic acids and acylglycines. Routinely, confirmatory testing requires enzymatic studies and DNA analysis. When an abnormal newborn screening result indicates a specific disorder, Sanger sequencing of the specific gene of interest can identify the underlying genetic cause of the disorder in many patients. However, biochemical screening results may show measurements that overlap with several conditions. Additionally, significant genetic heterogeneity has been reported for long-chain fatty acid oxidation disorders. These factors highlight the necessity, in some cases, of a comprehensive analysis of multiple genes involved in fatty acid oxidation; the MetaboSeq panel. We assessed the analytical sensitivity and specificity of this panel following microdroplet-based PCR target enrichment and next-generation sequencing (NGS). The NGS results were examined across several parameters, including sequencing metrics and genotype concordance with Sanger sequencing to assess the suitability of this panel for use in a diagnostic laboratory. MetaboSeq demonstrates the successful application of targeted enrichment and NGS to screen for mutations in hundreds of exons in diseases involved in multiple genes of a common pathway.
doi:10.4172/0974-276x.s1.002 fatcat:wi2doy74kffztk2x2b3nd3pyxm